Thyme oil's effects on respiratory symptoms in COPD patients
Effect of Thyme Oil on Respiratory Symptoms and Hemodynamic Parameters in COPD Patients
This study is testing if thyme oil can help improve breathing and overall health in people with COPD who are in the hospital.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Inonu University Academic / other |
| Locations | 1 site (Batman) |
| Trial ID | NCT06156449 on ClinicalTrials.gov |
What this trial studies
This study investigates the impact of thyme oil on respiratory symptoms and hemodynamic parameters in patients diagnosed with Chronic Obstructive Pulmonary Disease (COPD). It aims to explore the potential benefits of using thyme oil, a medicinal plant known for its antioxidant properties, in conjunction with standard pharmacological treatments. The study will enroll hospitalized COPD patients who are conscious and able to communicate, assessing their symptoms and health parameters over a specified period. The research is conducted at a training and research hospital in eastern Turkey.
Who should consider this trial
Good fit: Ideal candidates for this study are hospitalized COPD patients over 18 years of age who are conscious and willing to participate.
Not a fit: Patients under 18 years of age, those with mental disorders, or who are pregnant will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a novel complementary treatment option for improving respiratory health and quality of life in COPD patients.
How similar studies have performed: While the use of medicinal plants in treating respiratory conditions is common, the specific application of thyme oil in COPD patients is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Hospitalized with the diagnosis of COPD in the chest diseases service of a Training and Research Hospital located in the east of Turkey, * Receiving the patient on the first day of admission to the chest diseases service (Day 1). * Those who have been hospitalized in the chest diseases service for at least 3 days, * Over 18 years of age, * Being conscious, * Open to communication and cooperation, * Patients who volunteer to participate in the study will be included in the study. Exclusion Criteria: * Under 18 years of age, * Those with dementia and/or other organic mental disorders, * Those with mental retardation detected by clinical interview, * Those who have received any psychiatric diagnosis, * Those who are pregnant, * Those who do not want to participate in the research, * Patients transferred to intensive care or discharged will be excluded from the study.
Where this trial is running
Batman
- Batman Training and Research Hospital — Batman, Turkey (Recruiting)
Study contacts
- Study coordinator: Zeliha Cengiz, Associate Professor
- Email: zeliha.cengiz@inonu.edu.tr
- Phone: 904223410220
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.